Mostrando 2,761 - 2,780 Resultados de 15,611 Para Buscar '"pancreatic cancer"', tiempo de consulta: 0.37s Limitar resultados
  1. 2761
    “…The treatment paradigm for locally advanced pancreatic cancer (LAPC) is evolving rapidly. The development of neoadjuvant therapies composed of combination therapies and the evaluation of their impact on conversion to borderline resectable (BR) status, resection, and ultimately overall survival (OS) are presently being pursued. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 2762
  3. 2763
  4. 2764
    “…BACKGROUND: The prognosis of pancreatic cancer (PC) has been improved by new chemotherapy regimens (combination of 5-fluorouracil, oxaliplatin, irinotecan, and leucovorin (FOLFIRINOX) or gemcitabine plus nab-paclitaxel (GnP)). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  5. 2765
  6. 2766
    “…Pancreatic cancer (PC) is one of the most lethal forms of cancer, characterized by its aggressiveness and metastatic potential. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  7. 2767
    por Lu, Ye, Gentiluomo, Manuel, Macauda, Angelica, Gioffreda, Domenica, Gazouli, Maria, Petrone, Maria C., Kelemen, Dezső, Ginocchi, Laura, Morelli, Luca, Papiris, Konstantinos, Greenhalf, William, Izbicki, Jakob R., Kiudelis, Vytautas, Mohelníková-Duchoňová, Beatrice, Bueno-de-Mesquita, Bas, Vodicka, Pavel, Brenner, Hermann, Diener, Markus K., Pezzilli, Raffaele, Ivanauskas, Audrius, Salvia, Roberto, Szentesi, Andrea, Aoki, Mateus Nóbrega, Németh, Balázs C., Sperti, Cosimo, Jamroziak, Krzysztof, Chammas, Roger, Oliverius, Martin, Archibugi, Livia, Ermini, Stefano, Novák, János, Kupcinskas, Juozas, Strouhal, Ondřej, Souček, Pavel, Cavestro, Giulia M., Milanetto, Anna C., Vanella, Giuseppe, Neoptolemos, John P., Theodoropoulos, George E., van Laarhoven, Hanneke W. M., Mambrini, Andrea, Moz, Stefania, Kala, Zdenek, Loveček, Martin, Basso, Daniela, Uzunoglu, Faik G., Hackert, Thilo, Testoni, Sabrina G. G., Hlaváč, Viktor, Andriulli, Angelo, Lucchesi, Maurizio, Tavano, Francesca, Carrara, Silvia, Hegyi, Péter, Arcidiacono, Paolo G., Busch, Olivier R., Lawlor, Rita T., Puzzono, Marta, Boggi, Ugo, Guo, Feng, Małecka-Panas, Ewa, Capurso, Gabriele, Landi, Stefano, Talar-Wojnarowska, Renata, Strobel, Oliver, Gao, Xin, Vashist, Yogesh, Campa, Daniele, Canzian, Federico
    Publicado 2021
    “…Although 21 pancreatic cancer susceptibility loci have been identified in individuals of European ancestry through genome-wide association studies (GWASs), much of the heritability of pancreatic cancer risk remains unidentified. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 2768
    “…We aim to review rates of palliative care consultation in patients with advanced pancreatic cancer at our institution, intending to improve these rates. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  9. 2769
    “…Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase 4 (NOX4) is one of the seven isoforms of NOX family, which is upregulated in pancreatic cancer cell, mouse model of pancreatic cancer and human pancreatic cancer tissue. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  10. 2770
    “…This is particularly evident in pancreatic cancer, where limited responses to treatment underlie dismal survival rates, highlighting the urgent need for new therapeutic approaches. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 2771
    “…Pancreatic cancer is associated with highly malignant tumors and poor prognosis due to strong therapeutic resistance. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  12. 2772
    “…PURPOSE: Malnutrition is a common problem among pancreatic cancer (PC) patients that negatively impacts on their quality of life (QoL) and clinical outcomes. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  13. 2773
  14. 2774
  15. 2775
    “…We examined the impact of pharmacological RNS interference on overcoming the recruitment and immunosuppressive activity of tumor-expanded myeloid cells, which render pancreatic cancers resistant to immunotherapy. RESULTS: PDAC progression is marked by a stepwise infiltration of myeloid cells, which enforces a highly immunosuppressive microenvironment through the uncontrolled metabolism of L-arginine by arginase 1 and inducible nitric oxide synthase activity, resulting in the production of large amounts of reactive oxygen and nitrogen species. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  16. 2776
  17. 2777
    “…PURPOSE: Given the higher precision accompanied by optimized sparing of normal tissue, charged particle therapy was thought of as a promising treatment for pancreatic cancer. However, systematic preclinical studies were scarce. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 2778
    “…Dense fibrotic stroma, known as desmoplasia, is a characteristic feature of pancreatic cancer, and develops through the interactions between pancreatic cancer cells and stromal cells, including pancreatic stellate cells. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  19. 2779
    “…SIMPLE SUMMARY: Pancreatic cancer has a very poor prognosis. The few available therapeutic options are characterized by low efficacy and high toxicity due to the intrinsic chemoresistance of this tumor type. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  20. 2780
Herramientas de búsqueda: RSS